Preventing Hepatitis C in Prisons: The Role of Opioid Agonist Treatment (OAT)

Date
24 Jun 2025
12:00 PM - 01:30 PM

Cost
Free

Available to
All

Continuing Professional Development

RACGP: Pending accreditation with RACGP. ASHM is an RACGP-accredited CPD Provider under the RACGP CPD Program.

Online

ASHM, in collaboration with the National Prisons Hepatitis Network, invites you to a free national Lunch & Learn webinar exploring the critical role of Opioid Agonist Treatment (OAT) in preventing hepatitis C (HCV) in correctional settings.

Delivered by experts from across the country, the session features insights from the authors of the National Consensus Statement on OAT in custodial settings, alongside real-world experiences from New South Wales and Queensland correctional programs.

Designed for healthcare professionals, peer workers, policymakers, and anyone working to improve health in correctional settings.

For more information and to register, visit the ASHM website linked.

This event is supported by an unconditional education grant from Gilead Sciences. Sponsorship is provided in accordance with the ASHM’s Sponsorship Policy. ASHM does not endorse or promote any sponsor’s product or service.